AnX Robotica news

ANX ROBOTICA ANNOUNCES THE AMERICAN MEDICAL ASSOCIATION ISSUES UNIQUE CATEGORY III CPT® CODE FOR MAGNETICALLY CONTROLLED CAPSULE ENDOSCOPY

January 13, 2021 (Press Release) – PLANO, Texas. AnX Robotica Corporation, (www.anxrobotics.com), the developer and manufacturer of the NaviCam Magnetically Controlled Capsule Endoscopy (MCCE) System, is pleased to announce that the American Medical Association (AMA) has issued a new Current Procedural Terminology (CPT) code for Magnetically controlled capsule endoscopy, which can help clinicians to diagnose and treat patients with esophageal and stom

Jan. 13, 2021

ANX ROBOTICA RECEIVES FDA DE-NOVO CLASSIFICATION FOR FIRST-OF-ITS-KIND NAVICAM™ REMOTE-CONTROLLED CAPSULE ENDOSCOPY SYSTEM FOR THE STOMACH

Plano, Texas (June 4, 2020) AnX Robotica Corporation today announced it has been granted by the Food and Drug Administration (FDA) De-Novo classification for its NaviCamTM Magnetically Controlled Capsule Endoscopy (MCCE) System. The first-of-its-kind system allows complete, real-time visualization of the stomach utilizing a pill-sized capsule containing a camera and is remote-controlled by the physician using proprietary magnetic technologies.

Traditional capsule end

Jun. 4, 2020

ANX ROBOTICA CORP RECEIVES 510(K) CLEARANCE FROM FDA TO MARKET ITS INTRAMARX™ RADIOPAQUE MARKERS

AnX Robotica Corp receives 510(k) clearance from FDA to market its IntraMarX™ Radiopaque Markers

Plano, TX March 31st, 2020 – AnX Robotica Corp (AnX) today announced that it has received FDA 510(k) clearance to market its IntraMarX™ Radiopaque Markers (ROM).

Radiopaque markers are used to measure colon transit time and they are the most basic and primary tool in evaluating disorders of colonic motility. The radiopaque marker test is

Mar. 31, 2020